FierceBiotech 2025-12-13 GAO probe finds understaffed FDA putting some medical device recall work on the 'back burner'
FierceBiotech 2025-12-12 Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’
FierceBiotech 2025-12-12 Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share
FierceBiotech 2025-12-12 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says
FierceBiotech 2025-12-11 Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
FierceBiotech 2025-12-11 Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
FierceBiotech 2025-12-11 Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test
FierceBiotech 2025-12-11 FDA clears Lumosity brain training games as a prescription app for adult ADHD
FierceBiotech 2025-12-11 Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech
FierceBiotech 2025-12-11 Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs
FierceBiotech 2025-12-10 Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer
FierceBiotech 2025-12-10 Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal
FierceBiotech 2025-12-10 Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies